Regulating synaptic membrane exocytosis 4 (RIM4) is a protein that is believed to play a role in the complex process of synaptic transmission, specifically in the exocytosis of synaptic vesicles. Proteins that are involved in regulating synaptic membrane exocytosis are critical for the proper function of neurons, as they are directly implicated in the release of neurotransmitters into the synaptic cleft.Although specific details about RIM4 may not be as extensively documented as other proteins in the RIM (Rab3-interacting molecule) family, RIM proteins generally serve as important molecular scaffolds that organize the active zone of synapses. They interact with multiple proteins, including Rab3, Munc13, and RIM-binding proteins, to orchestrate the docking and priming of synaptic vesicles, preparing them for rapid release upon the arrival of an action potential.
The "4" in RIM4 suggests that it is one member of a larger family, and it may have unique or overlapping functions with other RIM proteins. RIM proteins typically contain several characteristic domains such as a zinc-finger domain, involved in protein-protein interactions, and a PDZ domain that can bind to C-terminal motifs of other synaptic proteins. These interactions ensure that the vesicles are correctly positioned at the presynaptic membrane and that the machinery necessary for vesicle fusion is assembled and regulated.Understanding the precise role of RIM4 in synaptic exocytosis would require detailed investigations, likely involving a combination of genetic, biochemical, and electrophysiological approaches. Studies may include analysis of RIM4 protein interactions, the effect of its overexpression or knockdown on synaptic function, and the identification of any unique regulatory elements within its structure. Elucidating the function of RIM4 could provide insights into synaptic plasticity mechanisms and the etiology of neurological disorders where synaptic dysfunction is a hallmark.
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
フォルスコリンはアデニリルシクラーゼを活性化し、cAMPレベルを上昇させる。これはPKA活性を高め、シナプス機能に関連する遺伝子をアップレギュレートする可能性がある。 | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMAはプロテインキナーゼC(PKC)を活性化し、シナプスタンパク質の合成を促進する転写因子をリン酸化する可能性がある。 | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
ロリプラムはPDE4を阻害し、cAMPレベルを上昇させ、CREBのリン酸化を促進し、シナプス可塑性に関連する遺伝子をアップレギュレートする。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
レチノイン酸はレチノイン酸受容体を介して遺伝子の転写に影響を及ぼし、シナプスタンパク質の発現に影響を及ぼす可能性がある。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
リチウムはGSK-3β活性を調節し、様々な転写因子に影響を与え、シナプス可塑性に関与する遺伝子をアップレギュレートする可能性がある。 | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
選択的セロトニン再取り込み阻害薬であるフルオキセチンは、神経細胞の活動を変化させ、シナプス蛋白質の遺伝子発現を変化させる可能性がある。 | ||||||
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $109.00 $369.00 | 2 | |
NMDA受容体作動薬はシナプス活性を調節し、シナプス可塑性に関連するタンパク質の発現に影響を与える可能性がある。 | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
ガバペンチンは電位依存性カルシウムチャネルのα2δサブユニットに結合し、神経伝達に関連する遺伝子発現に影響を与える可能性がある。 | ||||||